These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8846521)

  • 1. Nafamostat enhances IBMX and secretin-stimulated water and bicarbonate secretion in the isolated, blood-perfused dog pancreas.
    Horiuchi A; Iwatsuki K; Chiba S
    Clin Exp Pharmacol Physiol; 1995 Dec; 22(12):987-9. PubMed ID: 8846521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabexate and camostat, synthetic proteinase inhibitors, as direct inducing factors of water and bicarbonate secretion in the isolated and blood-perfused dog pancreas.
    Horiuchi A; Iwatsuki K; Yonekura H; Ren LM; Chiba S
    J Pharmacol Exp Ther; 1990 Jan; 252(1):320-6. PubMed ID: 1688943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the cyclic nucleotide phosphodiesterase inhibitors, rolipram, 3-isobutyl-1-methylxanthine, amrinone and zaprinast, on pancreatic exocrine secretion in dogs.
    Iwatsuki K; Horiuchi A; Ren LM; Chiba S
    Eur J Pharmacol; 1991 Dec; 209(1-2):63-8. PubMed ID: 1726088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual actions of glucagon: direct stimulation and indirect inhibition of dog pancreatic secretion.
    Horiuchi A; Iwatsuki K; Ren LM; Kuroda T; Chiba S
    Eur J Pharmacol; 1993 Jun; 237(1):23-30. PubMed ID: 7689468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cyclic nucleotide phosphodiesterase IV inhibitor, Ro20,1724, on pancreatic exocrine secretion in dog.
    Iwatsuki K; Ren LM; Chiba S
    Clin Exp Pharmacol Physiol; 1994 Sep; 21(9):701-7. PubMed ID: 7529665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of substance P on pancreatic exocrine secretion stimulated by secretin, dopamine and cholecystokinin in dogs.
    Iwatsuki K; Yamagishi F; Chiba S
    Clin Exp Pharmacol Physiol; 1986 Sep; 13(9):663-70. PubMed ID: 2433085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hydergine on pancreatic exocrine secretion in the isolated, blood-perfused pancreas of the dog.
    Iwatsuki K; Iijima F; Chiba S
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):328-34. PubMed ID: 6838289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a synthesized phosphodiesterase inhibitor, ZSY-27, on pancreatic exocrine secretion of the dog.
    Iwatsuki K; Yamagishi F; Chiba S
    Clin Exp Pharmacol Physiol; 1986 Jun; 13(6):487-94. PubMed ID: 3757312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of DN-9693, a synthesized phosphodiesterase inhibitor, on pancreatic exocrine secretion in dogs.
    Iwatsuki K; Horiuchi A; Yonekura H; Haruta K; Homma N; Chiba S
    Jpn J Pharmacol; 1989 Jan; 49(1):77-82. PubMed ID: 2470943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nicardipine on pancreatic exocrine secretion in the dog.
    Iwatsuki K; Ikeda K; Chiba S
    Clin Exp Pharmacol Physiol; 1982; 9(6):587-94. PubMed ID: 7166002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of prostaglandin output from secretin-stimulated exocrine secretion of the pancreas in dogs.
    Iwatsuki K; Horiuchi A; Yonekura H; Kuroda T; Chiba S
    Arch Int Pharmacodyn Ther; 1988; 291():263-71. PubMed ID: 2452610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of peptide histidine isoleucine on pancreatic exocrine secretion in anaesthetized dogs.
    Iwatsuki K; Ren LM; Chiba S
    Clin Exp Pharmacol Physiol; 1993; 20(7-8):501-7. PubMed ID: 8403531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of verapamil on pancreatic exocrine secretion induced by dopamine, secretin and pancreozymin in the dog.
    Iwatsuki K; Ikeda K; Chiba S
    Clin Exp Pharmacol Physiol; 1982; 9(2):165-72. PubMed ID: 7127915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allopurinol stimulates pancreatic exocrine secretion in the dog.
    Horiuchi A; Iwatsuki K; Yonekura H; Chiba S; Oguchi H
    Pancreas; 1989; 4(2):179-84. PubMed ID: 2755942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A secretin releasing peptide exists in dog pancreatic juice.
    Li P; Song Y; Lee KY; Chang TM; Chey WY
    Life Sci; 2000 Feb; 66(14):1307-16. PubMed ID: 10755466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine potentiates secretin-stimulated pancreatic exocrine secretion in the dog.
    Yamagishi F; Homma N; Haruta K; Iwatsuki K; Chiba S
    Eur J Pharmacol; 1985 Dec; 118(3):203-9. PubMed ID: 4085553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inhibitors of cyclic nucleotide phosphodiesterase on the actions of vasoactive intestinal peptide and secretin on pancreatic acini.
    Gardner JD; Korman LY; Walker MD; Sutliff VE
    Am J Physiol; 1982 Jun; 242(6):G547-51. PubMed ID: 6178297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of vasoactive intestinal peptide and secretin in stimulation of pancreatic secretion.
    Konturek SJ; Pucher A; Radecki T
    J Physiol; 1976 Feb; 255(2):497-509. PubMed ID: 1255530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of ouabain and acetazolamide on secretin-stimulated pancreatic exocrine secretion in anaesthetized dog.
    Iwatsuki K; Horiuchi A; Yonekura Y; Chiba S
    Clin Exp Pharmacol Physiol; 1989 Mar; 16(3):139-45. PubMed ID: 2498020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of KRN2391, a novel vasodilator, on pancreatic exocrine secretion in anesthetized dogs.
    Iwatsuki K; Horiuchi A; Ren LM; Chiba S
    Eur J Pharmacol; 1993 Nov; 249(1):19-24. PubMed ID: 8282016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.